← FDA DRUG APPROVALS

FDA ANDA · ANDA074610

CIMETIDINE HYDROCHLORIDE

Sponsor: ANI PHARMS

APPLICATION
ANDA074610
TYPE
ANDA
ORIGINAL APPROVAL
1996-09-26
LATEST ACTION
2001-08-30
ROUTE
ORAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

CIMETIDINE HYDROCHLORIDEDiscontinued
CIMETIDINE HYDROCHLORIDE EQ 300MG BASE/5ML · SOLUTION · ORAL

Approval history

2001-08-30Manufacturing (CMC) · Supplement 6AP
2000-07-07Manufacturing (CMC) · Supplement 5AP
2000-01-24Manufacturing (CMC) · Supplement 4AP
1997-10-28Manufacturing (CMC) · Supplement 3AP
1997-10-14Manufacturing (CMC) · Supplement 2AP
1997-04-07Manufacturing (CMC) · Supplement 1AP
1996-09-26OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →